ORTHO MCNEIL PHARMACEUTICAL CO has a total of 30 patent applications. Its first patent ever was published in 1996. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are DELONG MITCHELL A, ZHEJIANG DADE PHARMACEUTICAL GROUP CO LTD and REDDY E PREMKUMAR.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | Brazil | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Australia | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Hong Kong | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Pan Kevin | 5 |
#2 | Cardova Richard F | 3 |
#3 | Sanfilippo Pauline J | 3 |
#4 | Jetter Michele | 3 |
#5 | Silberstein Stephen D | 3 |
#6 | Meschino Joseph | 3 |
#7 | Sui Zhihua | 3 |
#8 | Jiang Weiqin | 3 |
#9 | Scott Malcolm | 3 |
#10 | Fitzpatrick Louis | 3 |
Publication | Filing date | Title |
---|---|---|
WO03039563A1 | Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium | |
WO03040117A1 | Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators | |
CN1229472A | Method for in vitro determination of erythropoietin bioactivity |